Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) +/- Daratumumab Treatment Results in Sustained Hematologic Response in Patients with AL Amyloidosis: A Retrospective Analysis of Patients at Mayo ClinicYael Kusne, Rafaël Fonseca, Jeremy T. Larsen et al.|Blood|2022Cited by 1
An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and EfficacyAdrienne Kaufman, Leslie Padrnos, Yael Kusne et al.|Blood|2021Cited by 0
Electrocardiogram As a Marker of Cardiac Response in Light Chain AmyloidosisRodrigo Fonseca, Julie Rosenthal, Rafaël Fonseca et al.|Blood|2022Cited by 0